DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Steven Rosenberg
Steven Rosenberg
THERAPEUTIC FOCUS Oncology Immunotherapy Is an Emerging Powerhouse in Cancer Treatment
Vince Devita: the View from the Top
Historical Overview of Immunotherapy
Bringing Til Therapy Beyond Melanoma: Advancing the Treatment of Advanced Pancreatic and Ovarian Cancers
Challenges and Next Steps in the Advancement of Immunotherapy: Summary of the 2018 and 2020 National Cancer Institute Workshops
Research Fellowships in Surgical Oncology and Cancer Immunotherapy
2011 MRA Retreat Agenda
Department of Health and Human Services Public Health Service National Cancer Institute
Gene Therapy Turns 30 Years Old the Dermatology Branch At
Immunotherapy: Gene Therapy for Soft-Tissue Tumors
Tandem Minigene (TMG): String of Minigenes Encoding the Mutated AA Flanked by 12 AA on Each Side
Corporate Presentation June 2017
The New Dawn of Immunotherapy
NCI Workshop on Cell-Based Immunotherapy for Solid Tumors Dec 10-11, 2018 | 6700B Rockledge Drive, Bethesda, MD MEETING AGENDA
T Cells As a Drug for the Personalized Immunotherapy of Cancer
Cancer Immunotherapies from Magic Bullets to Super T Cells
Dr. Steven Rosenberg's Achievements in Cancer Immunotherapy Motivate Young Researchers
773 Adoptive Cell Therapy Response in Melanoma Is Mediated by Stem
Top View
Adoptive T Cell Therapy for Lung Cancer Hurdles to Prime-Time Use
CONVERSATIONS with MIKE MILKEN Steven A. Rosenberg
CAR T-Cell Therapy a New Era in Cancer Treatment
Winning the War on Cancer and Medicare: Physician Practice Expenses
November 12, 2002, NIH Record, Vol. LIV, No. 23
January 17, 2014, NIH Record, Vol. LXVI, No. 2
'Serial Killers' Loose on Cancer
Speakers in Alphabetical Order
NCI's Dr. Steven Rosenberg to Present New TIL Trial Data in Scientific Symposium
Amendment Protocol Number: 13C0093-M Reference Number: 370214